early access to orphan drugs – the rationale, challenges and options available
Published 10 years ago • 274 plays • Length 20:38Download video MP4
Download video MP3
Similar videos
-
27:23
early access to orphan drugs -- the rationale, challenges and options available / mark corbett, glo
-
6:41
orphan drugs: an introduction
-
2:56
orphan drugs, exclusivity, and suing the fda
-
6:13
access & pricing of orphan drugs
-
9:12
orphan drug development | episode 01- what is orphan drug? | rare disease | drug regulatory affairs
-
28:20
12th orphan drugs & rare diseases global congress 2020 europe
-
4:11
what is an #orphan drug in #pharmaceutical #science?
-
1:54
what are the development challenges specific to orphan medicines?
-
2:33
what are the development challenges specific to orphan medicines?
-
17:20
discussion about the early access to experimental drugs eline bunnik
-
7:40
orphan drugs conquering rare diseases one-by-one
-
2:04
5 myths about orphan drugs and the orphan drug act
-
7:01
will orphan drugs find a home in the world of pharmaceutical r&d?
-
56:56
orphan drugs: making rare disease rarer
-
3:32
unveiling the mystery: what are orphan drugs?
-
25:26
5th eurordis survey on access to orphan drugs in europe
-
8:26
12 hour mba in orphan drugs - introduction
-
0:56
a global update on orphan drugs